If patients have a severe obesity-related complication including but not limited to hypertension, type 2 diabetes, CVD, dyslipidemia and a BMI of 27 mg/kg 2 or greater, then concurrent initiation of weight-loss medication with lifestyle interventions can be considered, according to the guideline
Diabetes 66(4):868879
Results Search Strategy From the original search, 40 articles underwent full review
Effects of Chuanhuang Formula combined with prostaglandin E1 in treating patients of chronic kidney disease complicated with acute kidney injury and its influence on NLRP3
122, 123, 124, 125 Insulin, for example, inhibits protein breakdown, facilitating the maintenance of positive nitrogen balance when protein is replaced with CHO